Suppression of inflammation and fibrosis using soluble epoxide hydrolase inhibitors enhances cardiac stem cell‐based therapy

Stem cell replacement offers a great potential for cardiac regenerative therapy. However, one of the critical barriers to stem cell therapy is a significant loss of transplanted stem cells from ischemia and inflammation in the host environment. Here, we tested the hypothesis that inhibition of the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirish, Padmini, Thai, Phung N., Lee, Jeong Han, Yang, Jun, Zhang, Xiao‐Dong, Ren, Lu, Li, Ning, Timofeyev, Valeriy, Lee, Kin Sing Stephen, Nader, Carol E., Rowland, Douglas J., Yechikov, Sergey, Ganaga, Svetlana, Young, Nilas, Lieu, Deborah K., Yamoah, Ebenezer N., Hammock, Bruce D., Chiamvimonvat, Nipavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Enabling Technologies for Cell‐based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695637/
https://www.ncbi.nlm.nih.gov/pubmed/32790136
http://dx.doi.org/10.1002/sctm.20-0143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695637/
https://www.ncbi.nlm.nih.gov/pubmed/32790136
http://dx.doi.org/10.1002/sctm.20-0143

Ejemplares similares